Authors:
de Haas, V
van der Schoot, CE
van den Berg, H
Citation: V. De Haas et al., Risk assessment in ALL in children: A focus on PCR-based techniques for MRD detection, ANN ONCOL, 12(5), 2001, pp. 587-592
Authors:
de Haas, V
Verhagen, OJHM
von dem Borne, AEGK
Kroes, W
van den Berg, H
van der Schoot, CE
Citation: V. De Haas et al., Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy, LEUKEMIA, 15(1), 2001, pp. 134-140
Authors:
de Haas, V
Oosten, L
Dee, R
Verhagen, OJHM
Kroes, W
van den Berg, H
van der Schoot, CE
Citation: V. De Haas et al., Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia, BR J HAEM, 111(4), 2000, pp. 1080-1086
Authors:
de Haas, V
Breunis, WB
Verhagen, OJ
van den Berg, H
van der Schoot, CE
Citation: V. De Haas et al., Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse, BLOOD, 96(4), 2000, pp. 1619-1620
Authors:
Pongers-Willemse, MJ
Verhagen, OJHM
Tibbe, GJM
Wijkhuijs, AJM
de Haas, V
Roovers, E
van der Schoot, CE
van Dongen, JJM
Citation: Mj. Pongers-willemse et al., Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes, LEUKEMIA, 12(12), 1998, pp. 2006-2014
Authors:
de Haas, V
Weber, ECC
de Klerk, JBC
Bakker, HD
Smit, GPA
Huijbers, WAR
Duran, M
Poll-The, BT
Citation: V. De Haas et al., The success of dietary protein restriction in alkaptonuria patients is age-dependent, J INH MET D, 21(8), 1998, pp. 791-798